These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10863063)

  • 1. A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer.
    Childs HA; Spencer SA; Raben D; Bonner JA; Newsome J; Robert F
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):939-44. PubMed ID: 10863063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.
    Pazdur R; Lassere Y; Diaz-Canton E; Bready B; Ho DH
    Invest New Drugs; 1997; 15(2):123-8. PubMed ID: 9220291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.
    Mani S; Kugler JW; Sciortino DF; Garcia JC; Ansari RH; Humerickhouse R; Michelassi F; Posner MC; Shulman KL; Schilsky RL; List M; Vokes EE; Benner S
    Ann Oncol; 1998 Sep; 9(9):1035-7. PubMed ID: 9818081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.
    Mackay HJ; Hill M; Twelves C; Glasspool R; Price T; Campbell S; Massey A; Macham MA; Uzzel M; Bailey SM; Martin C; Cunningham D
    Ann Oncol; 2003 Aug; 14(8):1264-9. PubMed ID: 12881390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
    Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R
    J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.
    Cellier P; Leduc B; Martin L; Vié B; Chevelle C; Vendrely V; Salemkour A; Carrie C; Calais G; Burtin P; Campion L; Boisdron-Celle M; Morel A; Berger V; Gamelin E
    BMC Cancer; 2011 Mar; 11():98. PubMed ID: 21410976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer.
    Schiebe ME; Reese T; Wenz F; Schmidberger H; Engenhart-Cabillic R; Dunst J; Hess CF; Hoffmann W
    Anticancer Drugs; 2002 Nov; 13(10):1005-9. PubMed ID: 12439334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
    Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B
    J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
    Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
    Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.
    Veronese ML; Stevenson JP; Sun W; Redlinger M; Algazy K; Giantonio B; Hahn S; Vaughn D; Thorn C; Whitehead AS; Haller DG; O'Dwyer PJ
    Eur J Cancer; 2004 Mar; 40(4):508-14. PubMed ID: 14962716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
    Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
    Tedesco KL; Berlin J; Blanke CD; Teng M; Choy H; Roberts J; Beauchamp RD; Leach S; Wyman K; Tarpley J; Shyr Y; Caillouette C; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1364-70. PubMed ID: 15817338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
    Mani S; Sciortino D; Samuels B; Arrietta R; Schilsky RL; Vokes EE; Benner S
    Invest New Drugs; 1999; 17(1):97-101. PubMed ID: 10555128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer.
    Pfeffer MR; Kundel Y; Zehavi M; Catane R; Koller M; Zmora O; Elkayam R; Symon Z
    Isr Med Assoc J; 2004 Oct; 6(10):595-8. PubMed ID: 15473585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study.
    Giralt J; Tabernero J; Navalpotro B; Capdevila J; Espin E; Casado E; Mañes A; Landolfi S; Sanchez-Garcia JL; de Torres I; Armengol M
    Radiother Oncol; 2008 Dec; 89(3):263-9. PubMed ID: 18768230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
    Byström P; Frödin JE; Berglund A; Wilking N; Glimelius B
    Radiother Oncol; 2004 Feb; 70(2):171-5. PubMed ID: 15028404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.